KZIANasdaq

KAZIA THERAPEUTICS LTD

Pharmaceutical Preparations · C3 · CIK 1075880

Kazia Therapeutics develops oncology drugs, focusing on brain cancer treatments like its lead candidate, Paxalisib

$163M

Market cap

$14.08

Last close

-2.6%

-4.2%

128K

Volume

Price · last 40 sessions+9.7%

May 4L $10.95 · H $14.69Jun 30

668

Total filings

Jun 2, 2026

Last filing

06/30

Fiscal year end

Similar companies

Comparable business profile · signals at a glance